Striae Distensae Treatment with a Skin Abrasion Device
Official title: Stretch Mark Treatment Using Subcutaneous Skin Abrasion
Run by Boston Children's Hospital · NCT07087405 · Data updated 2026-11-12
A device that abrades the skin under local anesthesia is tested to see if it can improve the appearance of stretch marks (striae distensae) and whether it is safe for patients.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Boston Children's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | May 28, 2026 |
| Trial ID | NCT07087405 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Individuals with striae distensae who are eligible and willing to undergo local anesthesia and biopsies at the Boston Children's Hospital site.
✕Probably not a fit
Patients who do not experience cosmetic improvement or who experience adverse events may not benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study tests a device designed to treat striae distensae by applying deep skin abrasion under local anesthesia. The trial will compare pre- and post-treatment appearance, monitor safety, and collect patient-reported outcomes. Participants will have biopsies, photographs, and surveys at defined timepoints, with follow-up visits at 1 week, 3 months, and 1 year. The lead site is Boston Children's Hospital, and no collaborators are listed; recruitment is limited to adults or children evaluated at that location depending on eligibility clarified by the site.
Why it matters
Potential benefit: If successful, the device could improve the cosmetic appearance of stretch marks for participants who receive it.
How similar studies have gone: There is limited public data on this exact deep dermal abrasion approach for striae distensae, so prior results are not conclusive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Striae distensae Exclusion Criteria: * Smoking * coagulation deficiency
Where it's running
-
Boston Children's Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Arin Greene, MD — Boston Children's Hospital
- Study coordinator: Arin Greene, MD
- Email: arin.greene@childrens.harvard.edu
- Phone: 16173552306
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Outcomes of tone-management surgery in children with spastic/dystonic quadriplegia
This study tests how well intrathecal baclofen pumps and dorsal/ventral rhizotomy help improve movement, comfort, and daily life for kids with severe CP and high muscle tone.
-
Hematopoietic stem cell editing to treat sickle cell disease
This study tests whether a patient’s own blood stem cells can be edited to remove the sickle cell triggering gene and then returned to the patient.
-
Wireless ultrasound monitor for fetal health in a single pregnancy
A single-center study will test a wireless adhesive ultrasound device on pregnant people with a singleton pregnancy to see if it can be worn comfortably and reliably for 10–30 minutes while collecting fetal and uterine data.
-
Monitoring leg pressure in teens with tibia fractures
A sensor is placed during surgery to see if measuring anterior leg pressure can help doctors spot acute compartment syndrome in teens with tibia fractures.
-
Indocyanine green for diagnosing biliary atresia
This test tries to see if a harmless fluorescent dye (indocyanine green) can show whether infants under 3 months with cholestasis have blocked bile ducts (biliary atresia).
-
Fetal embolization for vein of Galen malformation in late gestation
This study tests a one-time fetal embolization procedure for babies with vein of Galen malformations when the fetus is at least 34 weeks along.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.